Alopecia areata.
4/5 보강
TL;DR
Alopecia areata is a nonscarring, autoimmune, inflammatory, hair loss on the scalp, and/or body that is characterized by an increased number of the catagen and telogen follicles, the presence of inflammatory lymphocytic infiltrate in the peribulbar region (“swarm of bees”).
📑 코퍼스 인용 관계
· 인용됨 53
📑 인용한 논문 (6) ▾
- Exploring the Potential Links between Telogen Effluvium, Alopecia Areata, Pressure-Induced… Dermatology and therapy · 2026
- Sexual Dysfunction in Alopecia Areata: A Systematic Review. Journal of clinical medicine · 2025
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for mod… Frontiers in medicine · 2025
- Efficacy and Safety of Long-Term Azathioprine Therapy for Severe Alopecia Areata: A 10-Yea… Journal of cosmetic dermatology · 2025
- Factors Affecting the Response and Patient Satisfaction of Topical Immunotherapy in Alopec… Annals of dermatology · 2024
- Differential diagnosis of posterior scalp hair loss. Archives of dermatological research · 2024
연도별 인용 (2012–2026) · 합계 149
OpenAlex 토픽 ·
Hair Growth and Disorders
Autoimmune Bullous Skin Diseases
Dermatologic Treatments and Research
Abstract 🌐 Abstract
Alopecia areata (AA) is a nonscarring, autoimmune, inflammatory, hair loss on the scalp, and/or body. Etiology and pathogenesis are still unknown. The most common site affected is the scalp. Histopathology is characterized by an increased number of the catagen and telogen follicles, the presence of inflammatory lymphocytic infiltrate in the peribulbar region ("swarm of bees"). Corticosteroids are the most popular drugs for the treatment of this disease. Etiologic and pathogenic mechanisms, as well as other current treatments available will be discussed in this article.
Alopecia areata is a nonscarring, autoimmune, inflammatory, hair loss on the scalp, and/or body that is characterized by an increased number of the catagen and telogen follicles, the presence of infla
APA 7
Wasserman, D., Guzman-Sanchez, D. A., Scott, K., & McMichael, A. (2007). Alopecia areata.. International journal of dermatology, 46(2), 121-31. https://doi.org/10.1111/j.1365-4632.2007.03193.x
Vancouver
Wasserman D, Guzman-Sanchez DA, Scott K, McMichael A. Alopecia areata. Inte. jour. derm.. 2007;46(2):121-31. doi:10.1111/j.1365-4632.2007.03193.x
AMA 11
Wasserman D, Guzman-Sanchez DA, Scott K, McMichael A. Alopecia areata. Inte. jour. derm.. 2007;46(2):121-31. doi:10.1111/j.1365-4632.2007.03193.x
Chicago
Wasserman, D., Guzman-Sanchez, D. A., Scott, K., and McMichael, A.. 2007. "Alopecia areata." International journal of dermatology 46 (2): 121-31. https://doi.org/10.1111/j.1365-4632.2007.03193.x
MLA 9
Wasserman, D., et al. "Alopecia areata." International journal of dermatology, vol. 46, no. 2, 2007, pp. 121-31. doi:10.1111/j.1365-4632.2007.03193.x.
PMID
17269961 ↗
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
인용 관계
그래프 OA 노드: 7/8 (88%)
· 참조 0편 · 후속 7편
이 논문을 인용한 후속 연구 20
- Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990…
- What causes alopecia areata?
- Low-level laser (light) therapy (LLLT) for treatment of hair loss.
- Utility of dermoscopy in alopecia areata.
- Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata.
- Effects of the Lexington LaserComb on hair regrowth in the C3H/HeJ mouse model of alopecia areata.
- Genetic basis of alopecia areata: a roadmap for translational research.
- Immunology of alopecia areata.
- Modulation of Hair Growth Promoting Effect by Natural Products.
- Quality of life in alopecia areata: a sample of tunisian patients.
- Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model.
- Alopecia areata susceptibility variant in MHC region impacts expressions of genes contributing to ha…
- Prevalence of Alopecia Areata in Saudi Arabia: Cross-Sectional Descriptive Study.
- Comparative Evaluation of Therapeutic Efficacy of Intralesional Injection of Triamcinolone Acetonide…
- Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic…
- Thyroid disorders associated with alopecia areata in egyptian patients.
- Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implication of Post-Translational …
- The Frequency of Autoimmune Thyroid Disease in Alopecia Areata and Vitiligo Patients.
- Serum Interleukin-15 is a Marker of Alopecia Areata Severity.
- Clinicoepidemiological Observational Study of Acquired Alopecias in Females Correlating with Anemia …